Koninklijke Philips Shares Outstanding 2010-2023 | PHG

Koninklijke Philips shares outstanding history from 2010 to 2023. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • Koninklijke Philips shares outstanding for the quarter ending September 30, 2023 were 0.940B, a 2.96% increase year-over-year.
  • Koninklijke Philips 2023 shares outstanding were 0.917B, a 4.06% increase from 2022.
  • Koninklijke Philips 2022 shares outstanding were 0.882B, a 3.08% decline from 2021.
  • Koninklijke Philips 2021 shares outstanding were 0.91B, a 0.76% decline from 2020.
Koninklijke Philips Annual Shares Outstanding
(Millions of Shares)
2023 917
2022 882
2021 910
2020 917
2019 913
2018 936
2017 945
2016 929
2015 924
2014 923
2013 922
2012 927
2011 956
2010 948
2009 929
Koninklijke Philips Quarterly Shares Outstanding
(Millions of Shares)
2023-09-30 940
2023-06-30 947
2023-03-31 882
2022-06-30 884
2021-06-30 913
2020-06-30 914
2019-06-30 914
2018-06-30 929
2017-06-30 940
2016-12-31 929
2016-09-30 931
2016-06-30 918
2016-03-31 925
2015-12-31 924
2015-09-30 928
2015-06-30 915
2015-03-31 918
2014-12-31 923
2014-09-30 928
2014-06-30 917
2014-03-31 926
2013-12-31 922
2013-09-30 922
2013-06-30 916
2013-03-31 920
2012-12-31 927
2012-09-30 936
2012-06-30 927
2012-03-31 927
2011-12-31 939
2011-09-30 962
2011-06-30 970
2011-03-31 958
2010-12-31 953
2010-09-30 954
2010-06-30 949
2010-03-31 936
2009-12-31 933
2009-09-30 926
2009-06-30 902
2009-03-31 926
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $19.474B $19.663B
Koninklijke Philips N.V. is the parent company of the Philips Group. The company realigned its three reporting operations into Diagnosis & Treatment businesses consists of Diagnostic Imaging, Ultrasound, Image-Guided Therapy and Enterprise Diagnostic Informatics businesses. Connected Care business comprises the Monitoring & Analytics, Therapeutic Care, Population Health Management, Sleep & Respiratory Care and Connected Care Informatics businesses. Personal Health business consists of the Oral Healthcare, Mother & Child Care and Personal Care. Other consists of Innovation, Emerging Businesses, IP Royalties, Central costs and Other. Notably, Philips completed the divestiture of Domestic Appliances business.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $185.474B 24.35
Stryker (SYK) United States $128.161B 31.78
Boston Scientific (BSX) United States $106.966B 34.07
Medtronic (MDT) Ireland $106.730B 15.11
EssilorLuxottica (ESLOY) France $99.574B 0.00
Lonza Group Ag (LZAGY) Switzerland $42.648B 0.00
Haleon (HLN) United Kingdom $38.127B 29.82
ResMed (RMD) United States $27.032B 27.03
Terumo (TRUMY) Japan $25.476B 35.98
Zimmer Biomet Holdings (ZBH) United States $24.896B 16.03
Baxter (BAX) United States $20.785B 15.16
Insulet (PODD) United States $11.711B 61.49
Smith & Nephew SNATS (SNN) United Kingdom $10.741B 0.00
Demant (WILYY) Denmark $9.943B 0.00
Bio-Rad Laboratories (BIO) United States $7.934B 23.64
BellRing Brands (BRBR) United States $7.285B 39.17
Lantheus Holdings (LNTH) United States $4.470B 11.54
Haemonetics (HAE) United States $4.379B 22.40
Perrigo (PRGO) Ireland $4.232B 12.10
GN Store Nord (GNNDY) Denmark $3.937B 25.50
Envista Holdings (NVST) United States $3.485B 13.26
Prestige Consumer Healthcare (PBH) United States $3.482B 16.46
QuidelOrtho (QDEL) United States $2.730B 9.91
Neogen (NEOG) United States $2.679B 25.77
Green Thumb Industries (GTBIF) United States $2.630B 83.33
ICU Medical (ICUI) United States $2.357B 17.58
TG Therapeutics (TGTX) United States $2.161B 699.00
Maravai LifeSciences Holdings (MRVI) United States $1.928B 0.00
Owens & Minor (OMI) United States $1.895B 18.19
Verano Holdings (VRNOF) United States $1.790B 0.00
Agios Pharmaceuticals (AGIO) United States $1.780B 0.00
InMode (INMD) Israel $1.458B 7.55
LeMaitre Vascular (LMAT) United States $1.437B 47.43
National Vision Holdings (EYE) United States $1.388B 43.24
AdaptHealth (AHCO) United States $1.300B 9.78
Warby Parker (WRBY) United States $1.287B 0.00
AtriCure (ATRC) United States $1.115B 0.00
MacroGenics (MGNX) United States $0.982B 0.00
Canopy Growth (CGC) Canada $0.899B 0.00
BioLife Solutions (BLFS) United States $0.779B 0.00
Cresco Labs (CRLBF) United States $0.712B 0.00
VAREX IMAGING (VREX) United States $0.693B 14.98
Evolus (EOLS) United States $0.666B 0.00
Quanterix (QTRX) United States $0.613B 0.00
Jin Medical (ZJYL) China $0.547B 0.00
Valneva SE (VALN) France $0.540B 0.00
Phibro Animal Health (PAHC) United States $0.509B 11.02
PetIQ (PETQ) United States $0.487B 18.17
TerrAscend (TSNDF) Canada $0.478B 0.00
ZimVie (ZIMV) United States $0.430B 26.35
OraSure Technologies (OSUR) United States $0.421B 6.96
Biote (BTMD) United States $0.417B 3.96
Aurora Cannabis (ACB) Canada $0.393B 0.00
Surmodics (SRDX) United States $0.371B 40.11
Zynex (ZYXI) United States $0.361B 41.59
Viemed Healthcare (VMD) United States $0.314B 31.11
Cerus (CERS) United States $0.301B 0.00
Sanara MedTech (SMTI) United States $0.280B 0.00
TriSalus Life Sciences (TLSI) United States $0.274B 0.00
Utah Medical Products (UTMD) United States $0.241B 14.70
Organigram Holdings (OGI) Canada $0.199B 0.00
Veru (VERU) United States $0.193B 0.00
Ayr Wellness (AYRWF) United States $0.192B 0.00
Omeros (OMER) United States $0.176B 0.00
Quipt Home Medical (QIPT) United States $0.163B 0.00
High Tide (HITI) Canada $0.160B 0.00
Capricor Therapeutics (CAPR) United States $0.159B 0.00
Jushi Holdings (JUSHF) United States $0.134B 0.00
Eagleford Energy (GRUSF) United States $0.130B 65.20
FitLife Brands (FTLF) United States $0.129B 20.74
InterCure (INCR) Israel $0.122B 20.54
Fonar (FONR) United States $0.102B 8.80
Cellectar Biosciences (CLRB) United States $0.099B 0.00
MariMed (MRMD) United States $0.097B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.096B 0.00
Allurion Technologies (ALUR) United States $0.088B 0.00
Brainsway (BWAY) Israel $0.084B 0.00
Safety Shot (SHOT) United States $0.081B 0.00
Chimerix (CMRX) United States $0.081B 0.00
Zevia PBC (ZVIA) United States $0.060B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.059B 3.86
Apyx Medical (APYX) United States $0.052B 0.00
Cytosorbents (CTSO) United States $0.045B 0.00
Rockwell Medical (RMTI) United States $0.044B 0.00
ImmuCell (ICCC) United States $0.039B 0.00
United-Guardian (UG) United States $0.039B 15.04
Bright Green (BGXX) United States $0.037B 0.00
Modular Medical (MODD) United States $0.035B 0.00
Exagen (XGN) United States $0.024B 0.00
Nephros (NEPH) United States $0.023B 0.00
Flora Growth (FLGC) United States $0.020B 0.00
Agape ATP (ATPC) $0.020B 0.00
FSD PHARMA (HUGE) Canada $0.018B 0.00
Meihua Medical Technologies (MHUA) China $0.017B 0.00
Trinity Biotech (TRIB) Ireland $0.014B 0.00
GlucoTrack (GCTK) United States $0.013B 0.00
GUARDION HEALTH (GHSI) United States $0.010B 72.54
NeuroMetrix (NURO) United States $0.009B 0.00
IM Cannabis (IMCC) Canada $0.007B 0.00
Leafly Holdings (LFLY) United States $0.005B 0.00
Sharps Technology (STSS) United States $0.005B 0.00
Senestech (SNES) United States $0.004B 0.00
Innovative Eyewear (LUCY) United States $0.003B 0.00
Lucy Scientific Discovery (LSDI) Canada $0.002B 0.00
Akanda (AKAN) United Kingdom $0.001B 0.00
Smart For Life (SMFL) United States $0.001B 0.00
Bruush Oral Care (BRSH) $0.000B 0.00
SNDL (SNDL) Canada $0.000B 0.00